The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study

BACKGROUND: To investigate the efficacy and safety of moderate-intensity rosuvastatin/ezetimibe combination compared to highintensity rosuvastatin in high atherosclerotic cardiovascular disease (ASCVD) risk patients with type 2 diabetes mellitus (T2DM). METHODS: This study was a randomized, multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Jun Sung, Park, Il Rae, Kim, Sang Soo, Kim, Hye Soon, Kim, Nam Hoon, Kim, Sin Gon, Ko, Seung Hyun, Lee, Ji Hyun, Lee, Inkyu, Lee, Bo Kyeong, Won, Kyu Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695717/
https://www.ncbi.nlm.nih.gov/pubmed/38043782
http://dx.doi.org/10.4093/dmj.2023.0171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695717/
https://www.ncbi.nlm.nih.gov/pubmed/38043782
http://dx.doi.org/10.4093/dmj.2023.0171

Ejemplares similares